Skip to search formSkip to main contentSkip to account menu

aerosol therapy

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Treatment of lung cancer 3262 Bevacizumab ( Avastin ® ) aerosol therapy ( AT ) inhibits primary and metastatic tumor growth in a murine model with human non-small cell lung cancer ( NSCLC )
printing supported by . Visit Chiesi at Stand B2.10 TUESDAY, SEPTEMBER 4TH 2012 responders who received additional therapy with… 
2012
2012
Bevacizumab (Avastin®) aerosol therapy (AT) inhibits primary and metastatic tumor growth in a murine model with human non-small cell lung cancer (NSCLC)
Rationale: Avastin is used by systemic delivery only in lung cancer treatment, although the potential AT administration exists… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)